These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28704758)

  • 1. Deconstruction - reconstruction approach to analyze the essential structural elements of tetrahydro-3-benzazepine-based antagonists of GluN2B subunit containing NMDA receptors.
    Dey S; Temme L; Schreiber JA; Schepmann D; Frehland B; Lehmkuhl K; Strutz-Seebohm N; Seebohm G; Wünsch B
    Eur J Med Chem; 2017 Sep; 138():552-564. PubMed ID: 28704758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deconstruction - Reconstruction: Analysis of the Crucial Structural Elements of GluN2B-Selective, Negative Allosteric NMDA Receptor Modulators with 3-Benzazepine Scaffold.
    Ritter N; Korff M; Markus A; Schepmann D; Seebohm G; Schreiber JA; Wünsch B
    Cell Physiol Biochem; 2021 Mar; 55(S3):1-13. PubMed ID: 33656308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Methyltetrahydro-3-benzazepin-1-ols - The missing link in SAR of GluN2B selective NMDA receptor antagonists.
    Dey S; Schepmann D; Wünsch B
    Bioorg Med Chem; 2018 Jan; 26(2):501-508. PubMed ID: 29254894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the phenolic OH moiety of GluN2B-selective NMDA antagonists with 3-benzazepine scaffold.
    Dey S; Schepmann D; Wünsch B
    Bioorg Med Chem Lett; 2016 Feb; 26(3):889-893. PubMed ID: 26750254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists derived from 3-benzazepines: synthesis and pharmacological evaluation of benzo[7]annulen-7-amines.
    Benner A; Bonifazi A; Shirataki C; Temme L; Schepmann D; Quaglia W; Shoji O; Watanabe Y; Daniliuc C; Wünsch B
    ChemMedChem; 2014 Apr; 9(4):741-51. PubMed ID: 24677663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and σ
    Thum S; Schepmann D; Ayet E; Pujol M; Nieto FR; Ametamey SM; Wünsch B
    Eur J Med Chem; 2019 Sep; 177():47-62. PubMed ID: 31129453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacement of benzylic hydroxy group by vinyl or hydroxymethyl moiety at the 3-benzazepine scaffold retaining GluN2B affinity.
    Rath S; Schepmann D; Wünsch B
    Bioorg Med Chem; 2017 Oct; 25(20):5365-5372. PubMed ID: 28797770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenol-Benzoxazolone bioisosteres: Synthesis and biological evaluation of tricyclic GluN2B-selective N-methyl- d-aspartate receptor antagonists.
    Markus A; Schreiber JA; Goerges G; Frehland B; Seebohm G; Schepmann D; Wünsch B
    Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200147. PubMed ID: 35606894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, Pharmacological Evaluation and Docking Studies of GluN2B-Selective NMDA Receptor Antagonists with a Benzo[7]annulen-7-amine Scaffold.
    Gawaskar S; Temme L; Schreiber JA; Schepmann D; Bonifazi A; Robaa D; Sippl W; Strutz-Seebohm N; Seebohm G; Wünsch B
    ChemMedChem; 2017 Aug; 12(15):1212-1222. PubMed ID: 28749574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiomerically Pure 2-Methyltetrahydro-3-benzazepin-1-ols Selectively Blocking GluN2B Subunit Containing N-Methyl-D-aspartate Receptors.
    Tewes B; Frehland B; Schepmann D; Robaa D; Uengwetwanit T; Gaube F; Winckler T; Sippl W; Wünsch B
    J Med Chem; 2015 Aug; 58(15):6293-305. PubMed ID: 26186074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of the 4-phenylbutyl side chain of potent 3-benzazepine-based GluN2B receptor antagonists.
    Wagner M; Schepmann D; Ametamey SM; Wünsch B
    Bioorg Med Chem; 2019 Aug; 27(16):3559-3567. PubMed ID: 31255496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacement of the Benzylpiperidine Moiety with Fluorinated Phenylalkyl Side Chains for the Development of GluN2B Receptor Ligands.
    Thum S; Schepmann D; Kalinin DV; Ametamey SM; Wünsch B
    ChemMedChem; 2018 Dec; 13(23):2522-2529. PubMed ID: 30312542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxymethyl bioisosteres of phenolic GluN2B-selective NMDA receptor antagonists: Design, synthesis and pharmacological evaluation.
    Temme L; Frehland B; Schepmann D; Robaa D; Sippl W; Wünsch B
    Eur J Med Chem; 2018 Jan; 144():672-681. PubMed ID: 29289890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorinated GluN2B Receptor Antagonists with a 3-Benzazepine Scaffold Designed for PET Studies.
    Szermerski M; Börgel F; Schepmann D; Haider A; Betzel T; Ametamey SM; Wünsch B
    ChemMedChem; 2018 May; 13(10):1058-1068. PubMed ID: 29522653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, GluN2B affinity and selectivity of benzo[7]annulen-7-amines.
    Gawaskar S; Schepmann D; Bonifazi A; Wünsch B
    Bioorg Med Chem; 2014 Dec; 22(23):6638-6646. PubMed ID: 25458498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative allosteric modulators of the GluN2B NMDA receptor with phenylethylamine structure embedded in ring-expanded and ring-contracted scaffolds.
    Temme L; Bechthold E; Schreiber JA; Gawaskar S; Schepmann D; Robaa D; Sippl W; Seebohm G; Wünsch B
    Eur J Med Chem; 2020 Mar; 190():112138. PubMed ID: 32070917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical, pharmacodynamic and pharmacokinetic characterization of the GluN2B receptor antagonist 3-(4-phenylbutyl)-2,3,4,5-tetrahydro-1
    Korff M; Steigerwald R; Bechthold E; Schepmann D; Schreiber JA; Meuth SG; Seebohm G; Wünsch B
    Biol Chem; 2023 Mar; 404(4):279-289. PubMed ID: 36215695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, and Biological Evaluation of 3-Benzazepin-1-ols as NR2B-Selective NMDA Receptor Antagonists.
    Tewes B; Frehland B; Schepmann D; Schmidtke KU; Winckler T; Wünsch B
    ChemMedChem; 2010 May; 5(5):687-95. PubMed ID: 20340125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
    Tewes B; Frehland B; Schepmann D; Schmidtke KU; Winckler T; Wünsch B
    Bioorg Med Chem; 2010 Nov; 18(22):8005-15. PubMed ID: 20965739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiophene bioisosteres of GluN2B selective NMDA receptor antagonists: Synthesis and pharmacological evaluation of [7]annuleno[b]thiophen-6-amines.
    Baumeister S; Schepmann D; Wünsch B
    Bioorg Med Chem; 2020 Jan; 28(2):115245. PubMed ID: 31843460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.